United Health Products, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Brian D. Thom
- Full Time Employees
- 7
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 10624 South Eastern Avenue Mount Laurel NV United States of America 89052
- IPO Date
- Feb 14, 2007
- CIK
- 0001096938
- Website
- unitedhealthproductsinc.com
- Similar Companies
- Business
- United Health Products, Inc. (UEEC) develops, manufactures and markets hemostatic gauze products for the healthcare and wound care sectors, primarily focused on controlling bleeding in surgical, dialysis, dental and emergency medicine applications. The company offers its patented CelluSTAT Absorbable Hemostat, a biocompatible, pH neutral regenerated cellulose gauze derived from natural plant material that absorbs exudate, accelerates hemostasis in mild to moderate bleeding situations and is fully absorbable; it targets hospitals and surgery centers, clinics and physicians, military medical providers, hemodialysis centers, nursing homes, veterinary hospitals, EMS and first responders, as well as dental and maxillofacial surgery offices. Founded in 1997 and headquartered at 520 Fellowship Road, Suite D-406, Mount Laurel, New Jersey, the company operates principally in the United States through FDA-registered manufacturing partners. In recent developments, United Health Products submitted a Premarket Approval (PMA) application for CelluSTAT to the FDA on March 21, 2024, which remains under review to enable use in mild to moderate internal surgical bleeding; on November 29, 2024, it filed an Investigational Device Exemption (IDE) for a clinical trial involving approximately 30 subjects across 3-5 sites to demonstrate non-inferiority, superiority and safety versus standard care, while selecting a contract research organization, evaluating surgical sites and pursuing external funding from investors to minimize dilution. The company, formerly United EcoEnergy Corp. prior to its September 2010 name change, also plans board expansion with an audit committee, investor relations retention and potential uplisting to OTCQB in the first quarter of 2025, subject to capital raises.
United Health Products (OTCMKTS:UEEC) and QuidelOrtho (NASDAQ:QDEL) Financial Comparison
Head-To-Head Comparison: Insulet (NASDAQ:PODD) vs. United Health Products (OTCMKTS:UEEC)
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
Elucid's PlaqueIQ™ Image Analysis Software Now Covered by United Healthcare
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
United Health Products Provides Update on Clinical Study Process
United Health Products Submits Response Letter to FDA
United Health Products Submits Full FDA PMA Application
United Health Products Reports on FDA Application Status
The Medicare Gold Rush Is Slowing Down
United Health Products Reports on FDA Application Status
United Health Products Reports on Product Testing for FDA Application
Dow Stocks To Trade In June
Dow Stocks To Trade In December
Stocks To Trade In December
United Health Products Provides Corporate Update and Announces Equity Financing
United Health Products' HemoStyp® Gauze Advances to FDA Substantive Review